Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-group, Double-blind and Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Vilaprisan in Subjects With Uterine Fibroids

NCT03400956 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03400956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-group, Double-blind and Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Vilaprisan in Subjects With Uterine Fibroids
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Terminated
Start date
January 24, 2018
Completion date
June 30, 2021
Enrollment
103 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids